INTERNATIONAL PATENT: JIANGSU HENGRUI PHARMACEUTICALS CO., LTD., 江苏恒瑞医药股份有限公司 FILES APPLICATION FOR "PHARMACEUTICALLY ACCEPTABLE SALT OF DIHYDROPYRIDOPYRIMIDINE DERIVATIVE AND CRYSTAL FORM AND USE THEREOF"

GENEVA, Nov. 3 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (No.7 Kunlunshan Road, Economic And Technological Development ZoneLianyungang, Jiangsu 222047), 江苏恒瑞医药股份有限公司 (中国江苏省连云港市经济技术开发区昆仑山路7号) filed a patent application (PCT/CN2025/090918) for "PHARMACEUTICALLY ACCEPTABLE SALT OF DIHYDROPYRIDOPYRIMIDINE DERIVATIVE, AND CRYSTAL FORM AND USE THEREOF" on Apr 24, 2025. With publication no. WO/2025/223512, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was...